Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia-A systematic review

Gynecologic Oncology

Volumn 100, Issue 3, 2006, Pages 579-585

  Costa, Helio L F F ^a,c   Doyle, Pat ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NONE   (Brazil)

Author keywords

Contraceptives; Gestational trophoblastic neoplasms; Hydatidiform mole; Oral

Indexed keywords

CHORIONIC GONADOTROPIN;

CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; EMBASE; HUMAN; MEDLINE; META ANALYSIS; ORAL CONTRACEPTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TROPHOBLASTIC TUMOR;

EID: 32844459066     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.031     Document Type: Article

References (27)

1. H.O. Smith, and S.J. Kim Epidemiology B.W. Hancock E.S. Newlands R.S. Berkowitz L.A. Cole Gestational trophoblastic disease 2nd ed. 2003 International Society for the Study of Trophoblastic Disease 39 76 [cited 2004 Feb 11] Available from: http://www.isstd.org/index.html.
2. FIGO Committee on Gynecologic Oncology Staging classifications and clinical practice guidelines of gynaecologic cancers Int. J. Gynaecol. Obstet. 70 2000 207 312
3. A. Altieri, S. Franceschi, J. Ferlay, J. Smith, and C. La Vecchia Epidemiology and aetiology of gestational trophoblastic diseases Lancet Oncol. 11 2003 670 678
4. R.S. Berkowitz, and D.P. Goldstein Pathogenesis of gestational trophoblastic neoplasms Pathobiol. Annu. 11 1981 391 411
5. M. Stone, J. Dent, A. Dardana, and K.D. Bagshawe Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole Br. J. Obstet. Gynaecol. 83 1976 913 916
6. S.L. Curry, J.B. Schlaert, E.l. Kohorn, J.B. Boyce, H. Gore, L.B. Twiggs, and J.A. Blessing Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) Am. J. Obstet. Gynecol. 160 1989 805 809
7. R.E. Deicas, D.S. Miller, A.W. Rademaker, and J.R. Lurain The role of contraception in the development of postmolar trophoblastic tumour Obstet. Gynecol. 78 1991 221 226
8. Scientific Advisory Committee of the Royal College of Obstetricians and Gynaecologists. The management of gestational trophoblastic tumour. [cited 2004 Jan 13] Available at: URL: http://www.rcog.org.uk/guidelines.
9. L. Lajos, J. Borcs, J. Szekeley, I. Csaba, and S. Domany The immunologic and endocrinologic basis of successful transplantation of human trophoblast Am. J. Obstet. Gynecol. 89 1964 595 605
10. W.P. Jollie The persistence of trophoblast in extrauterine tissue in the rat Am. J. Anat. 106 1960 109
11. C. Gal, E.R. Simpson, J.C. Porter, P.C. MacDonald, and H.J. Bunchsbaum Failure of contraceptive steroids to modify human chorionic gonadotrophin secretion by hydatidiform mole tissue and choriocarcinoma cells in culture Steroids 37 1981 663 671
12. T. Maruo, H. Matsuo, T. Otani, M. Hoshina, and M. Machizuki Differential modulation of chorionic gonadotrophin (CG) subunit messenger ribonucleic acid levels and hCG secretion by progesterone in normal placenta and choriocarcinoma cultured in vitro Endocrinology 119 1986 855 864
13. The Society of Gynecologic Oncologists SGO's Guidelines for referral to a gynaecologic oncologist: Rationale and benefits: Trophoblastic disease Gynecol. Oncol. 78 2000 S13
14. R.S. Berkowitz, A.R. Marean, D.P. Goldstein, and M.R. Bernstein Oral contraceptives and post-molar trophoblastic tumours Lancet 2 1980 752
15. R.S. Berkowitz, D.P. Goldstein, A.R. Marean, and M. Bernstein Oral contraceptives and post-molar trophoblastic disease Obstet. Gynecol. 58 1981 474 477
16. R.S. Berkowitz, D.P. Goldstein, and M.R. Bernstein Oral contraceptives and post-molar trophoblastic disease Contracept. Deliv. Syst. 3 1982 114
17. G.L. Eddy, J.B. Schlaerth, R.H. Nalick, O. Gaddis Jr., R.M. Nakamura, and C.P. Morrow Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen Obstet. Gynecol. 62 1983 736 740
18. P. Morrow, R. Nakamura, J. Schlaerth, O. Gaddis Jr., and G. Eddy The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve Am. J. Obstet. Gynecol. 151 1985 906 914
19. M. Stone, and K.D. Bagshawe An analysis of the influence of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy Br. J. Obstet. Gynaecol. 86 1979 782 792
20. I.F. Adewole, A. Oladokun, A.O. Fawole, J.F. Olawuyi, and J.A. Adeleye Fertility regulatory methods and development of complications after evacuation of complete hydatidiform mole J. Obstet. Gynaecol. 20 2000 68 69
21. S.L. Curry, J.B. Schlaerth, E.I. Kohorn, J.B. Boyce, H. Gore, and L.B. Twiggs Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study) Am. J. Obstet. Gynecol. 160 1989 805 809
22. G.L. Goldberg, K. Cloete, B. Bloch, K. Wiswedel, and M.M. Altaras Medroxiprogesterone acetate in non-metastatic gestational trophoblastic disease Br. J. Obstet. Gynaecol. 94 1987 22 25
23. B. Ho Yuen, and P. Burch Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentration of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy Am. J. Obstet. Gynecol. 145 1983 214 217
24. R.E. Deicas, D.S. Miller, A.W. Rademaker, and J.R. Lurain The role of contraception in the development of postmolar gestational trophoblastic tumor Obstet. Gynecol. 78 1991 221 226
25. Utoro, A, Sutoto, Comparison on the need for chemotherapy of the hydatidiform mole patients who are using oral contraceptives and patients who are not. In: Lukman, PD, editor. Kongres Obstetri Ginekologie Indonesia; 1979 June 10-15; Yogyakarta, Indonesia; 1992. p. 590-3.
26. WHO Scientific Group on Gestational Trophoblastic Diseases. Gestational trophoblastic disease. WHO Technical Report Series 692 (1983) 1-81.
27. H.O. Schild Applied pharmacology 1980 Churchill Livingstone London